CZMWY - Buy This Ophthalmology Stock But Sell This One Says Bernstein Analyst: 'Innovation Is Key' | Benzinga
Innovation and digitalization have been in focus among ophthalmology majors.
The ophthalmology market is attractive, at an estimated $34 billion, with growth rates "in the mid-single digits across products that range from the clinic to the operating room to the pharmacy,” analyst Susannah Ludwig of Bernstein said in a note.
- Initiated coverage of Alcon AG (NYSE: ALC) with an Outperform rating and a price target of CHF 82 ($94.03).
- Initiated coverage of Carl Zeiss Meditec AG (OTC: CZMWY) with an Underperform rating and a price target of €76 ($82.31).
Check out ...